Endocrinology focuses on hormonal system and metabolic health. Learn about the diagnosis and treatment of diabetes, thyroid disorders, and adrenal conditions.
Send us all your questions or requests, and our expert team will assist you.
Effective treatment and management of hyperparathyroidism requires a coordinated approach that balances medical therapy, surgical options, and lifestyle adjustments. This page is designed for international patients seeking clear, evidence‑based guidance on how the condition is evaluated and treated at Liv Hospital. Approximately 1 in 1,000 adults worldwide develop primary hyperparathyroidism, and early intervention can prevent complications such as kidney stones, osteoporosis, and cardiovascular disease. Below, we outline the diagnostic pathway, therapeutic choices, postoperative care, and long‑term strategies that together form a comprehensive treatment and management plan.
Our multidisciplinary team—endocrinologists, endocrine surgeons, nutritionists, and rehabilitation specialists—works together to tailor each plan to the patient’s age, disease severity, and personal goals. Whether you are considering medication, minimally invasive surgery, or a combination of both, understanding each step will help you make informed decisions and feel confident in the care you receive.
Before selecting a specific treatment and management pathway, it is essential to grasp the underlying mechanisms of hyperparathyroidism. The condition arises when one or more of the parathyroid glands produce excess parathyroid hormone (PTH), leading to elevated calcium levels in the blood. Primary hyperparathyroidism is usually caused by a benign adenoma, while secondary forms result from chronic kidney disease or vitamin D deficiency.
Typical symptoms include fatigue, bone pain, frequent urination, and gastrointestinal disturbances. However, many patients are asymptomatic and are diagnosed incidentally through routine blood work. Accurate diagnosis hinges on a combination of laboratory tests and imaging studies, as shown in the table below.
These investigations allow clinicians to stage the disease, identify candidates for surgery, and tailor the overall treatment and management plan.
For patients who are not surgical candidates—such as those with significant comorbidities, mild disease, or personal preference—medical treatment and management focuses on controlling calcium levels and protecting bone health. The primary pharmacologic agents include:
Regular monitoring is crucial. Patients typically undergo serum calcium and PTH testing every 3–6 months, along with annual DEXA scans. Lifestyle counseling, such as limiting high‑oxalate foods and maintaining adequate fluid intake, complements pharmacotherapy. While medication can control symptoms, it does not cure the underlying glandular hyperactivity; therefore, many patients eventually transition to surgical treatment and management when feasible.
Surgery remains the definitive treatment and management for most cases of primary hyperparathyroidism. At Liv Hospital, endocrine surgeons employ state‑of‑the‑art minimally invasive parathyroidectomy (MIP) guided by intra‑operative PTH monitoring and high‑resolution imaging. The two main approaches are:
Key steps include pre‑operative localization, intra‑operative nerve monitoring to protect the recurrent laryngeal nerve, and rapid PTH assay to confirm removal of hyperfunctioning tissue. Post‑operative hypocalcemia is monitored closely, especially in patients with severe bone disease, and calcium supplementation is provided as needed.
Outcomes are excellent, with most patients experiencing normalization of calcium levels within weeks and significant improvement in bone density over the ensuing year. The minimally invasive approach reduces scar visibility—an important consideration for international patients concerned about postoperative aesthetics.
Successful treatment and management extends beyond the operating room. After parathyroidectomy, patients enter a structured follow‑up program that includes:
Liv Hospital’s international patient services coordinate these appointments, arrange tele‑consultations for patients returning to their home countries, and provide interpreter support to eliminate language barriers. Ongoing surveillance is essential because a small subset of patients may develop recurrent hyperparathyroidism, which can be addressed promptly with repeat imaging and, if necessary, re‑operation.
Even after definitive surgery, lifestyle choices play a pivotal role in sustaining the benefits of treatment and management. Patients are encouraged to adopt the following evidence‑based habits:
Regular check‑ins with Liv Hospital’s nutrition specialists ensure that these recommendations are personalized to cultural preferences and dietary restrictions common among international patients.
For patients with refractory disease or those who prefer non‑surgical routes, Liv Hospital participates in international clinical trials exploring novel agents such as selective PTH receptor antagonists and gene‑editing techniques. While still investigational, these therapies represent the future of hyperparathyroidism treatment and management. Participation is limited to eligible candidates who meet strict inclusion criteria and are willing to travel to Istanbul for trial visits. Our dedicated research coordinators handle visa assistance, accommodation, and translation services, ensuring a seamless experience for international participants.
Staying informed about emerging options allows patients to make proactive decisions and potentially access cutting‑edge care before it becomes widely available.
Liv Hospital combines JCI accreditation, a multilingual care team, and a comprehensive 360‑degree international patient service. From the moment you schedule an appointment, we arrange airport transfers, interpreter support, and comfortable accommodation near our state‑of‑the‑art facilities. Our endocrine specialists have extensive experience in both medical and surgical treatment and management of hyperparathyroidism, ensuring personalized, evidence‑based care that meets global standards.
Ready to take the next step toward optimal health? Contact Liv Hospital today to schedule a personalized consultation and discover how our international patient program can simplify your journey.
Liv Hospital Ulus
Assoc. Prof. MD. Seda Turgut
Endocrinology and Metabolism
Liv Hospital Ulus
Prof. MD. Demet Yetkin
Endocrinology and Metabolism
Liv Hospital Vadistanbul
Prof. MD. Berçem Ayçiçek
Endocrinology and Metabolism
Liv Hospital Vadistanbul
Prof. MD. Gönül Çatlı
Pediatric Endocrinology
Liv Hospital Vadistanbul
Prof. MD. Kubilay Ükinç
Endocrinology and Metabolism
Liv Hospital Bahçeşehir
Assoc. Prof. MD. Sevil Arı Yuca
Pediatric Endocrinology and Metabolic Diseases
Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ufuk Özuğuz
Endocrinology and Metabolism
Liv Hospital Bahçeşehir
Spec. MD. Hüseyin Çelik
Endocrinology and Metabolism
Liv Hospital Topkapı
Prof. MD. Mehmet Aşık
Endocrinology and Metabolism
Liv Hospital Topkapı
Prof. MD. Nujen Çolak Bozkurt
Endocrinology and Metabolism
Liv Hospital Ankara
Prof. MD. Banu Aktaş Yılmaz
Endocrinology and Metabolism
Liv Hospital Ankara
Prof. MD. Peyami Cinaz
Pediatric Endocrinology
Liv Hospital Ankara
Prof. MD. Serdar Güler
Endocrinology and Metabolism
Liv Hospital Ankara
Spec. MD. Elif Sevil Alagüney
Endocrinology and Metabolism
Liv Hospital Gaziantep
Prof. MD. Zeynel Beyhan
Endocrinology and Metabolic Diseases
Liv Hospital Gaziantep
Spec. MD. Tahsin Özenmiş
Endocrinology and Metabolism
Liv Hospital Samsun
Assoc. Prof. MD. Gülçin Cengiz Ecemiş
Endocrinology and Metabolism
Liv Hospital Samsun
Spec. MD. Esra Tutal
Endocrinology and Metabolic Diseases
Liv Bona Dea Hospital Bakü
MD. FİDAN QULU
Endocrinology and Metabolism
Spec. MD. Zümrüt Kocabey Sütçü
Pediatric Endocrinology
Liv Hospital Ulus + Liv Hospital Vadistanbul + Liv Hospital Topkapı
Prof. MD. Cengiz Kara
Pediatric Endocrinology
Send us all your questions or requests, and our expert team will assist you.
Hyperparathyroidism often presents with nonspecific symptoms such as persistent fatigue and generalized bone pain due to calcium loss from bones. Patients may experience increased thirst and urination because excess calcium interferes with kidney function. Gastrointestinal issues like nausea, constipation, or abdominal pain can also occur. In some cases, the disease is discovered incidentally during routine blood tests that reveal elevated calcium levels. Because symptoms overlap with many other conditions, a high index of suspicion and appropriate laboratory testing are essential for diagnosis.
The diagnostic work‑up begins with serum calcium measurement; values above 10.5 mg/dL raise suspicion. Confirmatory testing includes parathyroid hormone (PTH) levels, which are inappropriately high or normal despite hypercalcemia. Vitamin D status is assessed because deficiency can mask PTH elevation. Bone density scanning (DEXA) evaluates osteoporosis risk, while a sestamibi scan helps localize overactive parathyroid tissue. Additional imaging, such as ultrasound or CT, may be used for surgical planning. Together, these tests stage the disease, identify surgical candidates, and guide personalized treatment.
For patients who cannot undergo surgery due to comorbidities or personal preference, pharmacologic therapy aims to control serum calcium and protect bone health. Calcimimetics such as cinacalcet increase the sensitivity of calcium‑sensing receptors, reducing PTH secretion. Bisphosphonates inhibit bone resorption, mitigating osteoporosis risk. Vitamin D analogues correct deficiency and help stabilize calcium metabolism. Adequate hydration and a low‑calcium diet lower urinary calcium excretion, decreasing stone formation risk. Regular monitoring of calcium, PTH, and bone density every 3–6 months ensures treatment efficacy, though these measures do not cure the underlying glandular overactivity.
Surgery is the definitive cure for most primary hyperparathyroidism cases. At Liv Hospital, surgeons perform minimally invasive parathyroidectomy (MIP) when pre‑operative imaging localizes a single overactive gland. This technique uses a 2–3 cm incision, results in 1–2 day hospital stays, and offers a 95 % cure rate. If imaging is inconclusive or multiple glands are involved, a traditional bilateral neck exploration with a larger incision (5–7 cm) is performed, yielding a 98 % cure rate but longer recovery. Both approaches incorporate intra‑operative nerve monitoring and rapid PTH assays to confirm successful removal. Post‑operative hypocalcemia is monitored, and calcium supplementation is provided as needed.
After surgery, patients have serum calcium and PTH measured on day 1, day 3, and at the two‑week follow‑up to detect hypocalcemia, especially in those with severe pre‑operative bone disease. Bone density is re‑evaluated at 12 months to assess recovery of skeletal health. Renal function is monitored for patients with a history of kidney stones. Nutrition specialists guide calcium and vitamin D intake to avoid both deficiency and excess. Physical therapy is recommended for patients with osteoporosis to improve balance and reduce fracture risk. Liv Hospital’s international patient services coordinate these visits, offer tele‑consultations, and provide interpreter support to ensure seamless follow‑up.
Even after successful surgery, patients benefit from lifestyle measures that sustain normal calcium metabolism. A daily calcium intake of 1,000–1,200 mg from food sources, without excessive supplementation, maintains bone health. Keeping serum 25‑OH vitamin D between 30–50 ng/mL through sunlight, diet, or prescribed supplements stabilizes calcium absorption. Drinking 2–3 L of water daily reduces kidney stone risk. Regular weight‑bearing activities—such as brisk walking, resistance training, or yoga—strengthen bone density. Limiting high‑oxalate foods (e.g., spinach, rhubarb, nuts) is advised for those prone to calcium oxalate stones. Ongoing consultations with nutritionists ensure these recommendations respect cultural dietary preferences.
BlogDiabetes MellitusMay 14, 2026Understand what is glucose plasma, its normal range, and why fasting plasma glucose tests are the simplest,...
BlogDiabetes MellitusMay 14, 2026We explain what is an insulin injection kit used for, detailing its role in insulin therapy to support diab...
BlogDiabetes MellitusMay 14, 2026We explain what gland produces insulin and how it balances blood sugar with hormones like insulin, glucagon...
BlogDiabetes MellitusMay 14, 2026Understand what causes type 1 diabetes, including autoimmune triggers and environmental factors, with insig...
BlogEndocrinologyMay 14, 2026We provide clear insights on delayed puberty male, its common causes, and compassionate treatment to suppor...
BlogEndocrinologyMay 14, 2026Learn about the cause of hashimoto thyroid disease, including genetic and environmental factors. We provide...
Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.
Start Chat on WhatsApp or call us at +90 530 174 26 75